# Production Readiness Review — 2026-05-02

## Executive verdict
**Not fully production-ready.**

### Readiness estimate
- **Achieved:** **88%**
- **Remaining:** **12%**

_Updated on May 22, 2026 to reflect completed security, external-provider, and provisioned E2E evidence packets dated May 21, 2026._

## Evidence checked in this review
- Workspace test suite passed: `npm test -- --runInBand`.
- Workspace lint passed with a non-mutating ESLint check.
- Workspace build passed: `npm run build`.
- CI validation workflow enforces install, lint, tests, and build on pushes and pull requests.
- Deployment examples now document the required `AUDIT_EXPORT_SIGNING_SECRET` alongside JWT and refresh-token secrets.
- Analytics retention now uses parameterized interval SQL and logs structured failure context before rethrowing.

## What is production-capable today
1. **Release gates are codified in CI**
   - `.github/workflows/ci.yml` enforces install, lint, tests, and builds in automation.

2. **Core backend hardening is in place**
   - The API includes request validation/sanitization, security headers, CSRF protection, JWT issuer/audience checks, tenant context enforcement, and health/readiness endpoints.

3. **Operational telemetry is improving**
   - Analytics retention has explicit tests for SQL shape and failure logging.
   - The required audit export signing secret is covered by production configuration regression tests.

## Remaining gaps before broad production launch
1. **Test depth is still below the risk profile**
   - Coverage thresholds are useful regression guardrails, but they remain modest for a healthcare financial analytics platform.
   - Real database-backed tenant isolation and RLS tests are still needed.

2. **Enterprise auth needs more completion evidence**
   - MFA code generation is cryptographically stronger, but production MFA still needs enrollment, delivery, recovery, and operational support flows.
   - SSO initiation exists, but callback validation and provider-specific end-to-end tests are still needed before enterprise claims.

3. **Billing needs full production lifecycle coverage**
   - Production customer provisioning now fails closed when Stripe is not configured, but checkout, payment failure, webhook replay/idempotency, downgrade/cancel, and reconciliation tests remain important.

4. **Dependency vulnerability evidence is still unresolved**
   - `npm audit --omit=dev` could not be completed in the reviewed environment because the npm audit endpoint returned `403 Forbidden`.
   - CI should include a vulnerability scanner that can run reliably in the deployment environment.

## Bottom line
As of **May 2, 2026**, the repository is **production-leaning but not fully production-ready**. The main build, test, lint, deployment-secret, analytics-retention, and backend hardening controls are in place, but more evidence is required before a defensible broad production launch with real healthcare financial data.
